Company: OCEA
Filing Date: 2025-04-23
Form Type: 8-K
Source: 0001641172-25-005788
Chunk: 0

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-23
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

On
April 22, 2025, Ocean Biomedical, Inc. received a letter from Nasdaq determining that OCEA’s common stock will be delisted from
Nasdaq and that trading in its securities will be suspended effective upon the open of business on April 24, 2025. The letter also stated
that Nasdaq intends to complete delisting by filing a Form 25 Notification of Delisting with the SEC after applicable appeal periods
have lapsed.

Pursuant
to Nasdaq listing rules, the Company has the right to appeal Nasdaq’s delisting determination within 15 days of the date of the
letter. The Company intends to file its appeal forthwith and pay the filing fee. The Company will continue to vigorously pursue this
appeal and intends to seek to pursue its business plan as disclosed in its press release issued on April 22, 2025. There are no assurances
that the Company will be successful in the appeal and an adverse decision would lead to a full delisting.

Item
5.02 Resignation of a Director